Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About TMS International Corp. (TMS)

Page 1 of 2

TMS International Corp. (NYSE:TMS) has seen a decrease in support from the world’s most elite money managers recently.

At the moment, there are tons of metrics shareholders can use to monitor their holdings. Some of the most under-the-radar are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the elite money managers can outperform the broader indices by a solid margin (see just how much).


Just as important, bullish insider trading activity is another way to parse down the world of equities. There are a number of incentives for an insider to downsize shares of his or her company, but just one, very obvious reason why they would initiate a purchase. Many empirical studies have demonstrated the market-beating potential of this tactic if investors understand what to do (learn more here).

Keeping this in mind, it’s important to take a peek at the key action surrounding TMS International Corp. (NYSE:TMS).

How have hedgies been trading TMS International Corp. (NYSE:TMS)?

At the end of the first quarter, a total of 9 of the hedge funds we track were long in this stock, a change of 0% from the first quarter. With hedge funds’ capital changing hands, there exists an “upper tier” of notable hedge fund managers who were upping their stakes significantly.

According to our comprehensive database, Howard Marks’s Oaktree Capital Management had the largest position in TMS International Corp. (NYSE:TMS), worth close to $14.5 million, comprising 0.3% of its total 13F portfolio. Sitting at the No. 2 spot is Eric Edidin and Josh Lobel of Archer Capital Management, with a $6.4 million position; 1.1% of its 13F portfolio is allocated to the stock. Other hedgies that hold long positions include Alexander Mitchell’s Scopus Asset Management, Bill Miller’s Legg Mason Capital Management and Chuck Royce’s Royce & Associates.

Since TMS International Corp. (NYSE:TMS) has faced bearish sentiment from the entirety of the hedge funds we track, it’s easy to see that there lies a certain “tier” of hedgies that decided to sell off their positions entirely last quarter. Interestingly, Israel Englander’s Millennium Management dumped the largest position of the “upper crust” of funds we watch, comprising an estimated $0.6 million in stock., and Mike Vranos of Ellington was right behind this move, as the fund dumped about $0.3 million worth. These moves are interesting, as aggregate hedge fund interest stayed the same (this is a bearish signal in our experience).

What do corporate executives and insiders think about TMS International Corp. (NYSE:TMS)?

Insider purchases made by high-level executives is most useful when the company we’re looking at has seen transactions within the past six months. Over the last half-year time period, TMS International Corp. (NYSE:TMS) has experienced zero unique insiders buying, and 1 insider sales (see the details of insider trades here).

Let’s also review hedge fund and insider activity in other stocks similar to TMS International Corp. (NYSE:TMS). These stocks are Thermon Group Holdings Inc (NYSE:THR), The Gorman-Rupp Company (NYSEAMEX:GRC), ExOne Co (NASDAQ:XONE), John Bean Technologies Corporation (NYSE:JBT), and China Yuchai International Limited (NYSE:CYD). This group of stocks belong to the diversified machinery industry and their market caps are closest to TMS’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!